DSGN Design Therapeutics, Inc.

Fundamentals / CIK 0001807120 / USD

Design Therapeutics, Inc. reported $0 in revenue and a net loss of $74.09M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DSGN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$7.59M$3.80M$0-$65.27MFY 2020 Revenue: $226KFY 2020 Net Income: -$8.28M2020FY 2021 Net Income: -$35.53M2021FY 2022 Net Income: -$63.31M2022FY 2023 Net Income: -$66.86M2023FY 2024 Revenue: $0FY 2024 Net Income: -$49.59M2024FY 2025 Revenue: $0FY 2025 Net Income: -$69.79M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 -- -- -- $226K
Research & Development $59.13M $44.35M $57.06M $48.61M $24.78M $6.06M
Total Operating Expenses $79.47M $62.38M $78.19M $67.59M $35.83M $8.56M
Operating Income -$79.47M -$62.38M -$78.19M -$67.59M -$35.83M -$8.33M
EBITDA -$78.84M -$61.79M -$77.65M -$67.19M -$35.70M -$8.32M
Interest Income $9.68M $12.79M $11.33M -- -- --
Income Tax Expense $0 $0 -- -- -- --
Net Income -$69.79M -$49.59M -$66.86M -$63.31M -$35.53M -$8.28M
Basic EPS -$1.22 -$0.88 -$1.19 -$1.14 -$0.77 -$0.52
Diluted EPS -$1.22 -$0.88 -$1.19 -$1.14 -$0.77 -$0.52
Basic Shares Outstanding 57.3M 56.6M 56.0M 55.7M 45.9M 15.8M
Diluted Shares Outstanding 57.3M 56.6M 56.0M 55.7M 45.9M 15.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 --
Research & Development $16.93M $16.39M $14.38M $13.43M $14.59M $15.74M $15.38M $12.16M
Total Operating Expenses $22.23M $22.18M $19.71M $18.17M $19.31M $21.57M $20.42M $16.69M
Operating Income -$22.23M -$22.18M -$19.71M -$18.17M -$19.31M -$21.57M -$20.42M -$16.69M
EBITDA -$22.09M -$22.03M -$19.55M -$18.01M -$19.16M -$21.42M -$20.26M -$16.55M
Interest Income $1.94M $2.01M $2.07M $2.17M $2.31M $2.49M $2.70M $3.04M
Net Income -$20.29M -$20.16M -$17.64M -$16.00M -$17.00M -$19.08M -$17.71M -$13.65M
Basic EPS -$0.32 -$0.32 -$0.29 -- -$0.30 -$0.34 -$0.31 --
Diluted EPS -$0.32 -$0.32 -$0.29 -- -$0.30 -$0.34 -$0.31 --
Basic Shares Outstanding 63.0M 62.5M 61.4M -- 57.0M 56.9M 56.8M --
Diluted Shares Outstanding 63.0M 62.5M 61.4M -- 57.0M 56.9M 56.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $16.86M $22.56M $21.20M $26.50M $298.6M $2.38M
Short-Term Investments $203.0M $222.9M $260.6M $303.9M $85.50M $33.71M
Cash & Short-Term Investments $219.8M $245.5M $281.8M $330.4M $384.1M $36.09M
Other Current Assets -- -- -- -- $7.0K $25K
Total Current Assets $223.8M $248.0M $284.6M $335.1M $385.4M $36.23M
Property, Plant & Equipment, Net $981K $1.41M $1.69M $1.95M $1.51M $71K
Total Non-Current Assets $2.42M $4.05M $5.06M $6.02M $5.12M $283K
Total Assets $226.2M $252.1M $289.6M $341.1M $390.6M $36.52M
Accounts Payable $2.31M $2.19M $1.94M $3.02M $1.62M $1.40M
Total Current Liabilities $13.05M $8.46M $9.62M $10.78M $5.28M $2.33M
Other Non-Current Liabilities -- -- -- -- -- $145K
Total Non-Current Liabilities $645K $1.53M $2.33M $3.05M $3.14M $145K
Total Liabilities $13.70M $10.00M $11.96M $13.83M $8.43M $2.48M
Total Debt (incl. Leases) $1.53M $2.33M $3.05M $3.69M $3.63M --
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $1.0K
Retained Earnings -$297.0M -$227.2M -$177.6M -$110.8M -$47.46M -$11.92M
Accumulated Other Comp. Income $403K $475K $62K -$3.36M -$244K $156K
Total Stockholders' Equity $212.5M $242.1M $277.7M $327.3M $382.1M -$11.31M
Total Equity $212.5M $242.1M $277.7M $327.3M $382.1M -$11.31M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $15.25M $12.91M $12.77M $16.86M $15.09M $19.70M $13.67M $22.56M
Short-Term Investments $193.4M $194.5M $210.1M $203.0M $190.9M $196.6M $216.0M $222.9M
Cash & Short-Term Investments $208.6M $207.4M $222.8M $219.8M $206.0M $216.3M $229.7M $245.5M
Total Current Assets $214.0M $212.0M $227.0M $223.8M $209.0M $219.8M $233.6M $248.0M
Property, Plant & Equipment, Net $573K $694K $824K $981K $1.10M $1.26M $1.38M $1.41M
Total Non-Current Assets $2.85M $3.12M $3.39M $2.42M $2.74M $3.09M $3.83M $4.05M
Total Assets $216.8M $215.1M $230.4M $226.2M $211.8M $222.9M $237.5M $252.1M
Accounts Payable $2.08M $3.14M $2.28M $2.31M $1.91M $1.01M $3.18M $2.19M
Total Current Liabilities $12.75M $11.24M $10.19M $13.05M $11.17M $8.75M $8.24M $8.46M
Total Non-Current Liabilities $1.86M $2.03M $2.20M $645K $877K $1.10M $1.32M $1.53M
Total Liabilities $14.61M $13.27M $12.39M $13.70M $12.05M $9.85M $9.56M $10.00M
Total Debt (incl. Leases) $2.51M $2.66M $2.73M $1.53M $1.74M $1.95M $2.14M $2.33M
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$355.1M -$334.8M -$314.6M -$297.0M -$281.0M -$264.0M -$244.9M -$227.2M
Accumulated Other Comp. Income -$1.68M -$771K -$268K $403K $358K $305K $450K $475K
Total Stockholders' Equity $202.2M $201.9M $218.1M $212.5M $199.7M $213.0M $227.9M $242.1M
Total Equity $202.2M $201.9M $218.1M $212.5M $199.7M $213.0M $227.9M $242.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$69.79M -$49.59M -$66.86M -$63.31M -$35.53M -$8.28M
Depreciation & Amortization $622K $596K $537K $406K $129K $5.0K
Stock-Based Compensation $14.55M $13.07M $13.09M $10.93M $4.69M $450K
Operating Cash Flow -$54.36M -$43.10M -$58.56M -$51.32M -$29.38M -$8.67M
Capital Expenditure -$193K -$340K -$256K -$918K -$1.54M -$76K
Free Cash Flow -$54.55M -$43.45M -$58.82M -$52.23M -$30.91M -$8.74M
Purchases of Investments -$291.8M -$230.2M -$224.7M -$313.0M -$86.26M -$55.59M
Investing Cash Flow $22.91M $43.95M $52.54M -$221.0M -$53.64M -$33.56M
Common Stock Issued $24.85M $0 -- -- -- --
Financing Cash Flow $25.74M $513K $724K $235K $379.2M $44.53M
Net Change in Cash -$5.71M $1.36M -$5.30M -$272.1M $296.2M $2.30M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$20.29M -$20.16M -$17.64M -$16.00M -$17.00M -$19.08M -$17.71M -$13.65M
Depreciation & Amortization $136K $151K $157K $156K $155K $152K $159K $149K
Stock-Based Compensation $4.05M $3.87M $3.92M $3.44M $3.59M $3.98M $3.54M $3.47M
Operating Cash Flow -$15.38M -$15.52M -$16.43M -$11.97M -$11.16M -$14.44M -$16.79M -$9.86M
Capital Expenditure -$15K -$21K $0 -$34K $0 -$87K -$72K $0
Free Cash Flow -$15.39M -$15.54M -$16.43M -$12.00M -$11.16M -$14.53M -$16.86M -$9.86M
Purchases of Investments -$29.80M -$12.42M -$52.59M -$87.62M -$78.08M -$39.53M -$86.55M -$64.37M
Investing Cash Flow $189K $15.06M -$7.59M -$11.58M $6.51M $20.12M $7.87M $1.83M
Common Stock Issued $17.26M $0 $19.91M $24.85M $0 $0 $0 --
Financing Cash Flow $17.53M $605K $19.93M $25.32M $37K $361K $23K $263K
Net Change in Cash $2.35M $137K -$4.09M $1.77M -$4.62M $6.04M -$8.90M -$7.76M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -- -3685.8%
Net Profit Margin -- -- -- -- -- -3663.7%
Return on Equity (ROE) -32.8% -20.5% -24.1% -19.3% -9.3% --
Return on Assets (ROA) -30.9% -19.7% -23.1% -18.6% -9.1% -22.7%
Current Ratio 17.14x 29.31x 29.58x 31.10x 72.96x 15.55x
Quick Ratio 16.84x 29.01x 29.29x 30.66x 72.70x 15.49x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x --
5Y Revenue / Share Growth -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -36.6% -35.1% -32.0% -32.8% -33.8% -29.8% -24.7% -20.5%
Return on Assets (ROA) -34.2% -32.9% -30.3% -30.9% -31.8% -28.5% -23.7% -19.7%
Current Ratio 16.78x 18.86x 22.28x 17.14x 18.71x 25.13x 28.37x 29.31x
Quick Ratio 16.36x 18.45x 21.86x 16.84x 18.44x 24.73x 27.89x 29.01x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001807120) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal